The prospect that a pair of malaria drugs will become go-to medications for treating COVID-19 before they’ve been rigorously tested is prompting new safety warnings from heart specialists and other doctors and experts.
Trending
- Nigerian writer urges preservation of literary heritage amid writer shortage
- Health professionals brainstorm in Abuja, seek drug free society
- CAF announce dates for Champions League, Confederation Cup Finals
- Tayo Ayinde withdraws suit against Gani Adams, restates commitment to peace
- Those in corridors of power behind my ordeal – Segun Olatunji
- Remi Tinubu donates N1bn to aid fight against tuberculosis
- Police arrest two for alleged murder of former MD of Jigawa Housing Authority
- Man in police net for allegedly beating wife to death in Lagos